Clinical Experience with the Integrase Inhibitors Dolutegravir and Elvitegravir in HIV-infected Patients: Efficacy, Safety and Tolerance

  1. Cid-Silva, P.
  2. Llibre, J.M.
  3. Fernández-Bargiela, N.
  4. Margusino-Framiñán, L.
  5. Balboa-Barreiro, V.
  6. Pernas-Souto, B.
  7. Martín-Herranz, I.
  8. Castro-Iglesias, Á.
  9. Poveda, E.
Journal:
Basic and Clinical Pharmacology and Toxicology

ISSN: 1742-7843,  1742-7835

Year of publication: 2017

Volume: 121

Issue: 5

Pages: 442-446

Type: Article

DOI: 10.1111/BCPT.12828 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus